Cargando…
Shrinkage of Prostate and Improved Quality of Life: Management of BPH Patients with Croton membranaceus Ethanolic Root Extract
Benign prostatic hyperplasia (BPH) is an enlargement of the prostate. The study aimed at validating the use of freeze-dried Croton membranaceus ethanolic root extract for BPH management. Thirty-three patients were observed before and after 3-month administration of 20 mg t.i.d orally. The Internatio...
Autores principales: | Asare, George Awuku, Afriyie, Daniel, Ngala, Robert A., Appiah, Alfred A., Anang, Yvonne, Musah, Iddi, Adjei, Samuel, Bamfo-Quaicoe, Kwabena, Sule, Derick, Gyan, Ben A., Arhin, Peter, Edoh, Dominic A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4461762/ https://www.ncbi.nlm.nih.gov/pubmed/26106434 http://dx.doi.org/10.1155/2015/365205 |
Ejemplares similares
-
Calcium - Magnesium imbalance implicated in benign prostatic hyperplasia and restoration by a phytotherapeutic drug – Croton membranaceus Müll.Arg
por: Asare, George Awuku, et al.
Publicado: (2017) -
Endogenous Sphingolipid Signaling Pathway Implicated in the Action of Croton membranaceus on the Prostate Gland in BPH Patients
por: Asare, George Awuku, et al.
Publicado: (2017) -
Erratum to “Shrinkage of Prostate and Improved Quality of Life: Management of BPH Patients with Croton membranaceus Ethanolic Root Extract”
por: Evidence-Based Complementary and Alternative Medicine,
Publicado: (2019) -
Anti-atherogenic and anti-ischemic potentials of Croton membranaceus observed during sub-chronic toxicity studies
por: Afriyie, Dan K., et al.
Publicado: (2013) -
Lipid associated antioxidants: arylesterase and paraoxonase-1 in benign prostatic hyperplasia treatment-naïve patients
por: Asare, George Awuku, et al.
Publicado: (2018)